Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Prostate Cancer

Free Subscription Articles published in Cancer Lett Retrieve available abstracts of 40 articles: HTML format Text format

Single Articles

April 2012
1. GOYAL J , Antonarakis ES
   Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases.
   Cancer Lett. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. ZHANG L , Li L, Jiao M, Wu D, et al
   Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog-Gli1 pathway.
   Cancer Lett. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. YILDIRIM S , Altun S, Gumushan H, Patel A, et al
   Voltage-gated sodium channel activity promotes prostate cancer metastasis in vivo.
   Cancer Lett. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
4. MENSCHIKOWSKI M , Hagelgans A, Tiebel O, Vogel M, et al
   Regulation of thrombomodulin expression in prostate cancer cells.
   Cancer Lett. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. CHIAM K , Ricciardelli C, Bianco-Miotto T
   Epigenetic Biomarkers in Prostate Cancer: Current and Future Uses.
   Cancer Lett. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2012
6. PALUMBO A , Ferreira LB, Reis de Souza PA, de Oliveira FL, et al
   Extracellular matrix secreted by reactive stroma is a main inducer of pro-tumorigenic features on LNCaP prostate cancer cells.
   Cancer Lett. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. TREMBLEY JH , Unger GM, Korman VL, Tobolt DK, et al
   Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells.
   Cancer Lett. 2012;315:48-58.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
8. GRAY JK , Paluch AM, Stuart WD, Waltz SE, et al
   Ron receptor overexpression in the murine prostate induces prostate intraepithelial neoplasia.
   Cancer Lett. 2012;314:92-101.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
9. ZENG W , Wan R, Zheng Y, Singh SR, et al
   Hypoxia, stem cells and bone tumor.
   Cancer Lett. 2011;313:129-36.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. SINGH-GUPTA V , Banerjee S, Yunker CK, Rakowski JT, et al
    B-DIM Impairs Radiation-Induced Survival Pathways Independently of Androgen Receptor Expression and Augments Radiation Efficacy in Prostate Cancer.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
11. MA Y , Cheng Q, Ren Z, Xu L, et al
    Induction of IGF-1R expression by EGR-1 facilitates the growth of prostate cancer cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. SCHULZE J , Weber K, Baranowsky A, Streichert T, et al
    p65-dependent production of interleukin-1beta by osteolytic prostate cancer cells causes an induction of chemokine expression in osteoblasts.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. STEFFAN JJ , Koul HK
    Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
    Cancer Lett. 2011;310:109-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
14. DRYHURST D , McMullen B, Fazli L, Rennie PS, et al
    Histone H2A.Z prepares the prostate specific antigen (PSA) gene for androgen receptor-mediated transcription and is upregulated in a model of prostate cancer progression.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. SHAO Q , Ouyang J, Fan Y, Xie J, et al
    Prostate cancer in the senior men from rural areas in east district of China: Contemporary management and 5-year outcomes at multi-institutional collaboration.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. XU D , Lin TH, Li S, Da J, et al
    Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. CHEN CH , Liao CH, Chang YL, Guh JH, et al
    Protopine, a novel microtubule-stabilizing agent, causes mitotic arrest and apoptotic cell death in human hormone-refractory prostate cancer cell lines.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. FUZIO P , Ditonno P, Monica R, Battaglia M, et al
    Regulation of TGF-beta1 expression by Androgen Deprivation Therapy of prostate cancer.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
19. TSAUR I , Makarevic J, Hudak L, Juengel E, et al
    The cdk1-cyclin B complex is involved in everolimus triggered resistance in the PC3 prostate cancer cell line.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. TEPAAMORNDECH S , Huang L, Kirschke CP
    A null-mutation in the Znt7 gene accelerates prostate tumor formation in a transgenic adenocarcinoma mouse prostate model.
    Cancer Lett. 2011;308:33-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. HEO JY , Kim HJ, Kim SM, Park KR, et al
    Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN.
    Cancer Lett. 2011;308:71-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
22. HAN J , Jogie-Brahim S, Harada A, Oh Y, et al
    Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-kappaB signaling.
    Cancer Lett. 2011;307:200-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
23. CHOU YW , Chaturvedi NK, Ouyang S, Lin FF, et al
    Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
24. GAO L , Wu GJ, Liu XW, Zhang R, et al
    Suppression of invasion and metastasis of prostate cancer cells by overexpression of NDRG2 gene.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
25. YU S , Zhang Y, Yuen MT, Zou C, et al
    17-Beta-estradiol induces neoplastic transformation in prostatic epithelial cells.
    Cancer Lett. 2011;304:8-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
26. JUNG HJ , Suh SI, Suh MH, Baek WK, et al
    Pentamidine reduces expression of hypoxia-inducible factor-1alpha in DU145 and MDA-MB-231 cancer cells.
    Cancer Lett. 2011;303:39-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
27. DOWNS TM , Burton DW, Araiza FL, Hastings RH, et al
    PTHrP stimulates prostate cancer cell growth and upregulates aldo-keto reductase 1C3.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. PITCHAKARN P , Suzuki S, Ogawa K, Pompimon W, et al
    Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
29. JANG MJ , Baek SH, Kim JH
    UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. DAY JR , Jost M, Reynolds MA, Groskopf J, et al
    PCA3: from basic molecular science to the clinical lab.
    Cancer Lett. 2011;301:1-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
31. MACK JT , Helke KL, Normand G, Green C, et al
    ABCA2 transporter deficiency reduces incidence of TRAMP prostate tumor metastasis and cellular chemotactic migration.
    Cancer Lett. 2011;300:154-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. JIANG G , Zhao J, Xiao X, Tao D, et al
    AN N-terminal Smac peptide sensitizes human prostate carcinoma cells to methyl jasmonate-induced apoptosis.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. KIM SJ , Kelly WK, Fu A, Haines K, et al
    Genome-wide methylation analysis identifies involvement of TNF-alpha mediated cancer pathways in prostate cancer.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. WANG Q , Chen Z, Diao X, Huang S, et al
    Induction of autophagy-dependent apoptosis by the survivin suppressant YM155 in prostate cancer cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. AHMAD N , Kumar R
    Steroid hormone receptors in cancer development: a target for cancer therapeutics.
    Cancer Lett. 2011;300:1-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
36. MENG Q , Peng Z, Chen L, Si J, et al
    Nuclear Factor-kappaB modulates cellular glutathione and prevents oxidative stress in cancer cells.
    Cancer Lett. 2010;299:45-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. FERNANDEZ-MARTINEZ AB , Bajo AM, Isabel Arenas M, Sanchez-Chapado M, et al
    Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1.
    Cancer Lett. 2010;299:11-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. TIAN J , Peehl DM, Zheng W, Knox SJ, et al
    Anti-tumor and radiosensitization activities of the iron chelator HDp44mT are mediated by effects on intracellular redox status.
    Cancer Lett. 2010;298:231-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
39. WEDEL S , Hudak L, Seibel JM, Juengel E, et al
    Combined targeting of the VEGFr/EGFr and the mammalian target of rapamycin (mTOR) signaling pathway delays cell cycle progression and alters adhesion behavior of prostate carcinoma cells.
    Cancer Lett. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. KASSI E , Moutsatsou P
    Glucocorticoid receptor signaling and prostate cancer.
    Cancer Lett. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: